CVS Health appoints Teresa Heitsenrether to board; Larry Robbins resigns

CVS HEALTH Corp

Larry Robbins resigned from CVS Health board effective Aug 13, 2026; no disagreement cited.
Teresa Heitsenrether, JPMorgan Chief Data & Analytics Officer, appointed effective Nov 18, 2026.
Heitsenrether brings 40 years financial services experience; deemed independent under NYSE rules.
Robbins served since 2024 on Audit and Public Policy committees; departure after two years.
Robbins (Glenview CEO) cited improved financial performance and balance sheet repair during tenure.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Teresa Heitsenrether

Director

CVS · CVS HEALTH Corp

Effective: 2026-11-18
Filed: August 17, 2026, 4:19 PM ET

On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026.

Departed

Larry M. Robbins

Director

CVS · CVS HEALTH Corp

Effective: 2026-08-13
Filed: August 17, 2026, 4:19 PM ET

On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Teresa Heitsenrether was appointed as Director at CVS HEALTH Corp.

Action: appointed
Role: Director

Exact text from the filing

On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry M. Robbins resigned as Director at CVS HEALTH Corp.

Action: resigned
Role: Director

Exact text from the filing

On August 13, 2026, Larry M. Robbins notified the Board of Directors (the “Board”) of CVS Health Corporation (the “Company”) of his resignation from the Board, effective immediately.

View on SEC.gov

CVS HEALTH Corp filing history →

Source: SEC EDGAR

accession 0001193125-26-354096

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.